Efficacy of omega-6 essential fatty acid treatment before and after photorefractive keratectomy;Efficacité du traitement avec des acides gras essentiels oméga-6 administrés avant et après la kératectomie photoréfractive

Journal Francais d'Ophtalmologie

Volumn 31, Issue 3, 2008, Pages 282-286

  Querques, G ^a,b   Russo, V ^a   Barone, A ^a   Iaculli, C ^a   Delle Noci, N ^a  

^a UNIVERSITY OF FOGGIA   (Italy)

^b Ospedali Riuniti di Foggia   (Italy)

Author keywords

Apoptosis; Corneal healing; Dry eye; Micronutrition; Omega 6 essential fatty acids; PRK

Indexed keywords

ESSENTIAL FATTY ACID; OMEGA 6 FATTY ACID;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; MALE; PHOTOREFRACTIVE KERATECTOMY; POSTOPERATIVE COMPLICATION; PREOPERATIVE CARE; VISION TEST; VISUAL DISORDER;

ADULT; FATTY ACIDS, ESSENTIAL; FATTY ACIDS, OMEGA-6; FEMALE; HUMANS; MALE; PHOTOREFRACTIVE KERATECTOMY; POSTOPERATIVE COMPLICATIONS; PREOPERATIVE CARE; VISION DISORDERS; VISION TESTS;

EID: 42149145512     PISSN: 01815512     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0181-5512(08)74806-x     Document Type: Article

References (30)

1. Mietz H, Severin M, Seifert P, Esser P, Krieglstein GK. Acute corneal necrosis after excimer laser keratectomy for hyperopia. Ophthalmology 1999;106:490-6.
2. Fagerholm P. Wound healing after photorefractive keratectomy. J Cataract Refractive Surg 2002;6:432-47.
3. Wilson SE. Molecular cell biology for the refractive corneal surgeon: programmed cell death and wound healing. J Refractive Surgery 1997;13:171-5.
4. Wilson SE, He Y, Weing J, Li Q, McDowall AW, Vital M, et al. Epithelial injury induces keratocyte apoptosis: hypothesized role for the interleukin-1 system in the modulation of corneal tissue organization and wound healing. Exp Eye Res 1996;62:325-37.
5. Jones DT, Monroy D, Ji Z, Pflugfelder SC. Alteration of ocular surface of gene expression in Sjogren's Syndrome. Adv Exp Med Biol 1998;438:533-6.
6. Shreeve CM. Treating the dry eye. Opthalmic Optician 1982;25:650-1.
7. 1 levels in dry eye patients after treatment with essential fatty acids. [ARVO abstract] Invest Ophthalmol Vis Sci 2001;42:S259. Abstract nr.1398.
8. 1 defìciency. Treatment with essential fatty acids and vitamin C. Medical Hypotheses 1980;6:225-32.
9. Horrobin D. Essential fatty acid and prostaglandin metabolism in Sjogren's syndrome, systemic sclerosis and rheumatoid arthritis. Scand J Rheumatol Suppl 1986;61:242-5.
10. Horrobin D. Nutritional and medicaL importance of gamma-linoleic acid. Progr Lipid Res 1992;31:163-94.
11. Watson J, Byars ML, McGill P, Kelman AW. Cytokine and prostaglandin production by monocytes of volunteers and rheumatoid arthritis patients treated with dietary supplements of blackcurrant seed oil. Br J Rheum 1993;32:1055-8.
12. Kumar GS, Das UN. Effect of prostaglandins and their precursors on the proliferation of human lymphocytes and their secretion of tumor necrosis factor and various interleukins. Prostaglandin Leukot Essent Fatty Acids 1994;50:3312-34.
13. Purasiri P, Mckechnie A, Heys SD, Eremin O. Modulation in vitro of human natural cytotoxicity, lymphocyte proliferative response to mitogens and cytokine production by essential fatty acids. Immunology 1997;92:166-72.
14. Dirks J, Van-Aswegen CH, Du-Plessis DJ. Cytokine leveis affected by gamma-linolenic acid. Prostaglandin Leukot Essent Fatty Acids 1998;59:273-7.
15. De Luca P, Rossetti RG, Alavian C, Karim P, Zurier RB. Effects of gamma-linolenic acid on interleukin-1β and tumor necrosis factor-α secretion by stimulated human peripheral blood monocytes: studies in vitro and in vivo. J Invest Med 1999;47:246-50.
16. Caffrey B. Influence of diet on tear function. Optometry and Vision Sciences 1991;68:58-72.
17. 1 levels in dry eye patients after treatment with essential fatty acids. [ARVO abstract] Invest Ophthalmol Vis Sci 2001;42:S259. Abstract nr.1398.
18. Sommer A, Green WR. Goblet cell response to vitamin A treatment for corneal xerophthalmia. Am J Ophthalmol 1982;94:213-5.
19. Sommer A. Effects of vitamin A defìciency on the ocular surface. Am J Ophthalmol 1983;90:592-600.
20. Huang AJ, Tseng SCG, Kenyon KR. Change of paracellular permeability of ocular surface epithelium by vitamin A defìciency. Invest Ophthalmol Vis Sci 1991;32:633-9.
21. Patel S, Ferrier C, Plaskow J. Effects of systemic ingestion of vitamin and trace element dietary supplements on the stability of the precorneal tear film in normal subjects. In: Sullivan DA, ed. Lacrimal glands, tear film, and dry eye syndromes. New York: Plenum Press, 1994:285-7.
22. Brown NAP, Bron AJ, Harding JJ, Dewer HM. Nutrition supplements and the eye. Eye 1998;12:127-33.
23. Paterson CA, O'Rourke MC. Vitamin C levels in human tears. Arch Ophthalmol 1987;105:376-7.
24. Macri A, Giuffrida S, Amico V, Iester M, Traverso CE. Effect of linoleic acid and gamma-linoleic acid on tear production, tear clearance and on the ocular surface after photorefractive keratectomy. Graefes Arch Clin Exp Ophthalmol. 2003;241:561-6.
25. Sridhar MS, Rao SK, Vajpayee RB, Aasuri MK, Hannush S, Sinha R. Complications of laser-in-situ-keratomileusis. Indian J Ophthalmol 2002; 50: 265-82.
26. Ang RT, Dartt DA, Tsubota K. Dry eye after refractive surgery. Curr Opin Ophthalmol 2001;12:318-22.
27. Park WC and Tseng SC. Modulation of Acute Inflammation and Keratocyte Death by Suturing, Blood, and Amniotic Membrane in PRK Invest Ophthalmol Vis Sci 2000;41:2906-14.
28. Aragona P, Bucolo C, Spinella R, Giuffrida S, Ferreri G. Systemic Omega-6 Essential Fatty Acid Treatment and PGE1 Tear Content in Sjögren's Syndrome Patients. Invest Ophthalmol Vis Sci 2005;46:4474-9.
29. Stern ME, Pflugfelder SC. Inflammation in dry eye. The Ocular Surface 2004;2:124-30.
30. Kunert KS, Tisdale AS, Stern ME, Smith JA, Gipson IK. Analysis of topical cyclosporine treatment of patients with dry eye syndrome: effect on conjunctival lymphocytes. Arch Ophthalmol 2000;118:1489-96.